Some tumours are cancerous, but not all cancers can form tumours. How are cancers different from the abnormal pumps you ...
Padcev is approved for use in combination with the programmed death 1 inhibitor Keytruda (pembrolizumab) or Keytruda QLEX (pembrolizumab and berahyaluronidase alfa-pmph) as neoadjuvant treatment and ...
From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...
Credit: Thinkstock Investigators conducted a network meta-analysis of phase 3 trials on MIBC treatments to provide comparative ranking of perioperative therapies. Findings from studies over 30 years ...
Source: Getty Images The 2025 EAU guidelines provide updated insights into risk factors, diagnosis, classification, treatment, and follow-up of patients with muscle-invasive and metastatic bladder ...
New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...
When childhood cancer treatment ends, the emotional impact often does not. A new study published in the Nature journal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback